校際選修

115-1 選課時程

進行中

  • 初選第一階段 6/15/2026
  • 初選第二階段 6/22/2026
  • 校際選修 8/24/2026
  • 初選第三階段 8/31/2026
  • 開學後加退選 9/7/2026
  • 逾期加退選 9/21/2026
選課資源

臨床口腔癌化特論(二)

Clinical Oral Oncology (II)

學期
108-2
學分
2 學分
當期課號
B329
永久課號
A6579
開課單位
牙醫學系
授課教師
黎萬君、楊政杰、洪佩詩、涂曦丰
校區
陽明
類別
選修
上課時間表
週五
7
15:30–16:20
臨床口腔癌化特論(二)
YD209
2 節連堂
8
16:30–17:20

* 根據陽明交大上課時間表所列

週次計畫
週次主題
第 1 週ATG12 deficiency and mitochondrial biogenesis in tumor oncosis (I)Introduction
第 2 週ATG12 deficiency and mitochondrial biogenesis in tumor oncosis (II)Imaging of head and neck cancer
第 3 週MHC class I antigen presentation and immune evasion in cancer (I)Surgical pathology of oral premalignant lesion
第 4 週MHC class I antigen presentation and immune evasion in cancer (II)Surgical pathology of oral cavity cancer
第 5 週HolidaySurgical management of oral cavity cancer-neck dissection
第 6 週Endocytosis-mediated mitochondrial transplantation (I)Surgical management of oral cavity cancer-mouth floor and tongue
第 7 週Endocytosis-mediated mitochondrial transplantation (II)Surgical management of oral cavity cancer-gingiva and retromolar trigone
第 8 週CDK4/6 inhibition in head and neck squamous cell carcinoma (I)Surgical management of oral cavity cancer-lip and buccal mucosa
第 9 週CDK4/6 inhibition in head and neck squamous cell carcinoma (II)Exam I
第 10 週Long noncoding RNA MIR31HG in cancer (I)Surgical management of oral cavity cancer-soft and hard palate
第 11 週Long noncoding RNA MIR31HG in cancer (II)Surgical management of oral cavity cancer-maxilla
第 12 週ZNF185 and p63 in squamous cell carcinoma development (I)Surgical management of salivary gland tumors
第 13 週ZNF185 and p63 in squamous cell carcinoma development (II)Reconstruction-pedical flap
第 14 週Lipid signaling and proteolytic rewiring of mitochondria (I)Reconstruction-free tissue transfer
第 15 週Lipid signaling and proteolytic rewiring of mitochondria (II)Complications of head and neck oncosurgery
第 16 週CD24 signaling and cancer immunotherapy (I)Management of recurrent diseases
第 17 週HolidayCurrent treatment modality of oral cavity cancer
第 18 週CD24 signaling and cancer immunotherapy (II)Exam II